.After antibody-drug conjugate (ADC) specialist Seagen was offered to Pfizer in 2013 for a tremendou...
.On the heels of a stage 3 win that neglected to excite clients, Ironwood Pharmaceuticals is actuall...
.Don't quit Monte Rosa Therapeutics right now. The Boston-based biotech is actually having a ball af...
.Invite to recently's Chutes & Ladders, our roundup of notable management hirings, firings and re...
.Celebrating his firm's upsized going public (IPO), Septerna CEO Jeffrey Finer called the position b...
.AbbVie has come back to the source of its antipsychotic giant Vraylar looking for an additional hit...
.GenSight Biologics is actually weeks out of losing amount of money. Again. The biotech just has ade...
.Monopar Therapies is recouping a medicine from the dump of AstraZeneca's rare disease pipeline. It ...
.With new information out on Arcus Biosciences' speculative HIF-2a prevention, one team of experts f...
.After forming a gene therapy collaboration along with Dyno Therapies in 2020, Roche is actually bac...